Search Results - "Burns, James M"

Refine Results
  1. 1

    A step forward for an attenuated blood-stage malaria vaccine by Burns, Jr, James M

    Published in BMC medicine (09-11-2018)
    “…Efforts to develop an effective malaria vaccine have encountered multiple challenges, and have had limited success to date. As the need remains urgent, novel…”
    Get full text
    Journal Article
  2. 2

    Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination by Parzych, Elizabeth M, Miura, Kazutoyo, Long, Carole A, Burns, Jr, James M

    Published in PloS one (29-04-2020)
    “…Eradication of Plasmodium falciparum malaria will likely require a multivalent vaccine, but the development of a highly efficacious subunit-based formulation…”
    Get full text
    Journal Article
  3. 3

    Host-parasite interactions revealed by Plasmodium falciparum metabolomics by Olszewski, Kellen L, Morrisey, Joanne M, Wilinski, Daniel, Burns, James M, Vaidya, Akhil B, Rabinowitz, Joshua D, Llinás, Manuel

    Published in Cell host & microbe (19-02-2009)
    “…Intracellular pathogens have devised mechanisms to exploit their host cells to ensure their survival and replication. The malaria parasite Plasmodium…”
    Get full text
    Journal Article
  4. 4

    Na+ Influx Induced by New Antimalarials Causes Rapid Alterations in the Cholesterol Content and Morphology of Plasmodium falciparum by Das, Sudipta, Bhatanagar, Suyash, Morrisey, Joanne M, Daly, Thomas M, Burns, Jr, James M, Coppens, Isabelle, Vaidya, Akhil B

    Published in PLoS pathogens (01-05-2016)
    “…Among the several new antimalarials discovered over the past decade are at least three clinical candidate drugs, each with a distinct chemical structure, that…”
    Get full text
    Journal Article
  5. 5

    Design and Evaluation of Chimeric Plasmodium falciparum Circumsporozoite Protein-Based Malaria Vaccines by Stump, William H, Klingenberg, Hayley J, Ott, Amy C, Gonzales, Donna M, Burns, Jr, James M

    Published in Vaccines (Basel) (25-03-2024)
    “…Efficacy data on two malaria vaccines, RTS,S and R21, targeting circumsporozoite protein ( CSP), are encouraging. Efficacy may be improved by induction of…”
    Get full text
    Journal Article
  6. 6

    Inclusion of an Optimized Plasmodium falciparum Merozoite Surface Protein 2-Based Antigen in a Trivalent, Multistage Malaria Vaccine by Eacret, Jacqueline S, Parzych, Elizabeth M, Gonzales, Donna M, Burns, Jr, James M

    Published in The Journal of immunology (1950) (15-04-2021)
    “…merozoite surface protein ( MSP)2 is a target of parasite-neutralizing Abs. Inclusion of recombinant MSP2 (r MSP2) as a component of a multivalent malaria…”
    Get full text
    Journal Article
  7. 7

    A Chimeric Plasmodium falciparum Merozoite Surface Protein Vaccine Induces High Titers of Parasite Growth Inhibitory Antibodies by Alaro, James R, Partridge, Andrea, Miura, Kazutoyo, Diouf, Ababacar, Lopez, Ana M, Angov, Evelina, Long, Carole A, Burns, Jr, James M

    Published in Infection and Immunity (01-10-2013)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  8. 8

    Immunization with merozoite surface protein 2 fused to a Plasmodium-specific carrier protein elicits strain-specific and strain-transcending, opsonizing antibody by Eacret, Jacqueline S., Gonzales, Donna M., Franks, Raymond G., Burns, James M.

    Published in Scientific reports (21-06-2019)
    “…Vaccine trials and cohort studies in Plasmodium falciparum endemic areas indicate that naturally-acquired and vaccine-induced antibodies to merozoite surface…”
    Get full text
    Journal Article
  9. 9

    Enhanced Protection against Malaria by a Chimeric Merozoite Surface Protein Vaccine by Shi, Qifang, Lynch, Michelle M, Romero, Margarita, Burns, James M. Jr

    Published in Infection and Immunity (01-03-2007)
    “…The 42-kDa processed fragment of Plasmodium falciparum merozoite surface protein 1 (MSP-1₄₂) is a prime candidate for a blood-stage malaria vaccine. Merozoite…”
    Get full text
    Journal Article
  10. 10

    γδ T Cells but Not NK Cells Are Essential for Cell-Mediated Immunity against Plasmodium chabaudi Malaria by Weidanz, William P, LaFleur, GayeLyn, Brown, Andrew, Burns, James M. Jr, Gramaglia, Irene, van der Heyde, Henri C

    Published in Infection and Immunity (01-10-2010)
    “…Blood-stage Plasmodium chabaudi infections are suppressed by antibody-mediated immunity and/or cell-mediated immunity (CMI). To determine the contributions of…”
    Get full text
    Journal Article
  11. 11

    Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys by Burns, Jr, James M, Miura, Kazutoyo, Sullivan, JoAnn, Long, Carole A, Barnwell, John W

    Published in Malaria journal (15-03-2016)
    “…The production of properly folded, recombinant sub-unit Plasmodium falciparum malaria vaccine candidates in sufficient quantities is often a challenge. Success…”
    Get full text
    Journal Article
  12. 12

    Elevated Levels of the Plasmodium yoelii Homologue of Macrophage Migration Inhibitory Factor Attenuate Blood-Stage Malaria by Thorat, Swati, Daly, Thomas M, Bergman, Lawrence W, Burns, James M. Jr

    Published in Infection and Immunity (01-12-2010)
    “…The excessive production of proinflammatory cytokines plays a significant role in the pathogenesis of severe malaria. Mammalian macrophage migration inhibitory…”
    Get full text
    Journal Article
  13. 13

    Evaluation of the Immunogenicity and Vaccine Potential of Recombinant Plasmodium falciparum Merozoite Surface Protein 8 by ALARO, James R, ANGOV, Evelina, LOPEZ, Ana M, HONG ZHOU, LONG, Carole A, BURNS, James M

    Published in Infection and Immunity (01-07-2012)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  14. 14

    Host erythrocyte environment influences the localization of exported protein 2, an essential component of the Plasmodium translocon by Meibalan, Elamaran, Comunale, Mary Ann, Lopez, Ana M, Bergman, Lawrence W, Mehta, Anand, Vaidya, Akhil B, Burns, Jr, James M

    Published in Eukaryotic cell (01-04-2015)
    “…Malaria parasites replicating inside red blood cells (RBCs) export a large subset of proteins into the erythrocyte cytoplasm to facilitate parasite growth and…”
    Get full text
    Journal Article
  15. 15

    Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection by Alaro, James R, Lynch, Michele M, Burns, James M

    Published in Vaccine (04-10-2010)
    “…Abstract An efficacious malaria vaccine remains elusive despite concerted efforts. Using the Plasmodium yoelii murine model, we previously reported that…”
    Get full text
    Journal Article
  16. 16

    Remarkable stability in patterns of blood-stage gene expression during episodes of non-lethal Plasmodium yoelii malaria by Cernetich-Ott, Amy, Daly, Thomas M, Vaidya, Akhil B, Bergman, Lawrence W, Burns, Jr, James M

    Published in Malaria journal (06-08-2012)
    “…Microarray studies using in vitro cultures of synchronized, blood-stage Plasmodium falciparum malaria parasites have revealed a 'just-in-time' cascade of gene…”
    Get full text
    Journal Article
  17. 17

    Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection by Petritus, Patricia M, Burns, Jr, James M

    Published in The Journal of immunology (1950) (01-01-2008)
    “…Immunization with Plasmodium yoelii merozoite surface protein (PyMSP)-8 protects mice from lethal malaria but does not prevent infection. Using this merozoite…”
    Get full text
    Journal Article
  18. 18

    Prediction of Merozoite Surface Protein 1 and Apical Membrane Antigen 1 Vaccine Efficacies against Plasmodium chabaudi Malaria Based on Prechallenge Antibody Responses by Lynch, Michelle M., Cernetich-Ott, Amy, Weidanz, William P., Burns, James M.

    Published in Clinical and Vaccine Immunology (01-03-2009)
    “…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  19. 19

    Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant Pfs25, a Leading Transmission-Blocking Vaccine Candidate by Parzych, Elizabeth M, Miura, Kazutoyo, Ramanathan, Aarti, Long, Carole A, Burns, James M

    Published in Infection and immunity (01-01-2018)
    “…Challenges with the production and suboptimal immunogenicity of malaria vaccine candidates have slowed the development of a Plasmodium falciparum multiantigen…”
    Get full text
    Journal Article
  20. 20

    Protection against Plasmodium chabaudi Malaria Induced by Immunization with Apical Membrane Antigen 1 and Merozoite Surface Protein 1 in the Absence of Gamma Interferon or Interleukin-4 by BURNS, James M, FLAHERTY, Patrick R, NANAVATI, Payal, WEIDANZ, William P

    Published in Infection and Immunity (01-10-2004)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article